Clinical Trial Update: COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria [Phase 3]

View source ↗

Summary

Phase 3 trial comparing COREG MR to TOPROL-XL for reducing microalbuminuria in patients with hypertension and heart failure was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension

Drugs mentioned

• COREG MR (carvedilol)
• TOPROL XL (METOPROLOL SUCCINATE)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Heart Failure, Congestive and Microalbuminuria | Phase 3 | Status: TERMINATED